Hay Fever News and Research

RSS

Hay fever (pollen allergy) is one of the most common kinds of allergies. About 35 million Americans suffer from hay fever. Pollen is made by trees, grasses, and weeds. During the spring, summer, and fall some plants release pollen into the air you breathe. Your symptoms might be different at different times of the year. It all depends on the kinds of plants that grow where you live and what allergies you have.

Latest allergy research presented at EAACI Congress 2012

Ground-breaking research results about stress during pregnancy and changes in pollen potency across Europe will be presented - among other novel research - at the world's leading congress on allergy and immunology - the EAACI Congress 2012 - that will open tomorrow in Geneva, Switzerland.

16 Jun 2012

Hay fever vaccine shows efficacy in phase IIa trial

A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.

14 Jun 2012

European study on allergies investigates birch, olive and grass pollens

From Finland to Italy and from Spain to Lithuania, thirteen research institutes from eleven European countries took part in the three-year Hialine study. The coordinator was Professor Dr Jeroen Buters of TUM's Chair of Molecular Allergology and the Center of Allergy & Environment.

22 May 2012

Allergies may provide benefit by keeping away noxious environmental toxins

Yale researchers suggested Wednesday that allergies may be an outgrowth of the protective mechanism of the body to protect itself from noxious substances in the environment.

26 Apr 2012

Study: Sharp increase in airborne pollens across Europe

When trees and plants release their pollen, millions of hay fever sufferers are affected by sneezing fits and itchy, watery eyes. Today in Germany, roughly every fourth person suffers from allergies - and this figure is set to rise. Climate change is seen as one of the factors fuelling the increase in allergic responses.

17 Apr 2012

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

The unseasonably warm weather is making this spring season difficult for millions of Americans who suffer from asthma and allergies. To help adults and children who have symptoms find out if they are at risk, allergists will conduct the 16th annual Nationwide Asthma Screening Program, expanding the program this year to include screening for nasal allergies.

16 Apr 2012

FDA approves Teva's QNASL nasal aerosol corticosteroid

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.

26 Mar 2012

Allergy season comes early with high pollen counts

After the end of an unusually warm winter the spring has come early and this has affected asthmatics in parts of the South and Midwest this year. The 25 to 35 percent of people who suffer from hay fever, the early arrival of warm weather meant an unusually early start to allergy season due to the abundance of pollens.

25 Mar 2012

AAFA releases new 'Spring Allergy Capital' rankings

Today is the vernal equinox – otherwise known as the official end of winter and the start of spring. But even if you didn't look at your calendar today, chances are your nose already figured it out. That's because more than 40 million Americans have nasal allergies.

20 Mar 2012

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announced today positive results of three studies of MP29-02 (tentatively called Dymista), a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate.

5 Mar 2012

NAET safe and effective in treating children with allergy-related autism

Researchers at the NAET Autism Treatment Center in Buena Park, CA, hypothesized that major contributors to the development and symptoms of autism include food and nutrient sensitivities. They applied NAET, a combination of a special form of acupressure and kinesiology, to desensitize subjects to multiple allergens as a way to treat symptoms of autism.

31 Jan 2012

New First Choice infographic explores issue of SAD and winter blues

First Choice, one of the UK's leading leisure travel companies, has released an infographic that sheds light on how the lack of sunshine during the winter months is affecting a large proportion of the population in northern countries.

24 Nov 2011

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced results from a large Phase III clinical study of ciclesonide nasal aerosol, a corticosteroid formulated with a hydrofluoroalkane (HFA) propellant, intended for the treatment of allergic rhinitis.

5 Nov 2011

Reduced diversity of intestinal microbiota associated with increased risk of allergic disease

Oversensitivity diseases, or allergies, now affect 25 per cent of the population of Denmark. The figure has been on the increase in recent decades and now researchers at the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), University of Copenhagen, are at last able to partly explain the reasons.

3 Nov 2011

Winter health and safety tips

Winter is a special time for celebration. It should also be a time for added caution if you or someone in your family is an older adult. It is the season for falls, slips on icy streets, and other dangers that can be especially harmful for older adults. "Something as simple as a fall can be devastating for older men and women," says Dr. Evelyn Granieri, director of the Division of Geriatrics at NewYork-Presbyterian Hospital/The Allen Hospital. "Before the cold weather arrives, it is important to prepare."

20 Oct 2011

Emissions from livestock farms cause lung patients living nearby to experience more exacerbations

Emissions from livestock farms cause asthma and COPD patients living nearby to experience more exacerbations, according to research presented today at the European Respiratory Society's Annual Congress in Amsterdam.

28 Sep 2011

Yoghurt consumption whilst pregnant linked to asthma and hay fever in offsping

Women who eat low-fat yoghurt while pregnant increase their chances of having children who develop asthma and hay fever, a study has found. Belief till now was completely the opposite.

21 Sep 2011

Eating low-fat yoghurt whilst pregnant can increase risk of asthma, hay fever in children

Eating low-fat yoghurt whilst pregnant can increase the risk of your child developing asthma and allergic rhinitis (hay fever), according to recent findings.

19 Sep 2011

Scientists identify potential target that could combat allergies of early childhood

A pandemic of ailments called the "allergic march" -- the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood -- has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.

16 Aug 2011

Tips for preventing allergy during ragweed pollen season

Feel like there's no end in sight when it comes to fall allergy misery? Blame global warming. Research suggests that with global warming, nasal allergy during the ragweed pollen season - also called hay fever or seasonal allergic rhinitis - lasts up to three weeks longer than it used to, and the further north you live, the longer you have to wait for relief.

16 Jul 2011